Nuchev Ltd (ASX: NUC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Nuchev Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $13.05 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 90.03 million
Earnings per share -0.116
Dividend per share N/A
Year To Date Return -13.16%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Nuchev Ltd (ASX: NUC)
    Latest News

    Share Gainers

    Why Iron Road, Nuchev, Telix, & Treasury Wine shares are pushing higher today

    Iron Road Limited (ASX:IRD) and Treasury Wine Estates Ltd (ASX:TWE) shares are two of four pushing notably higher on Thursday...

    Read more »

    ⏸️ Shares to Watch

    Should you buy these 2 ASX dairy shares instead of A2 Milk?

    Could you replace Kiwi giant A2 Milk Company Ltd (ASX: A2M) with these 2 ASX dairy shares?

    Read more »

    $10, $20 and $50 noted planted in the dirt signifying asx growth shares
    Growth Shares

    A2 Milk and 1 other top ASX growth share to buy this month

    Here we look at 2 quality ASX growth shares to consider adding to your ASX share portfolio: A2 Milk Company…

    Read more »

    laptop, newspaper, ipad, coffee and hands holding iphone
    Share Market News

    3 quarterly updates you might have missed: Champion Iron, Life360, & Nuchev

    It isn't just St Barbara Ltd (ASX:SBM) and IGO Ltd (ASX:IGO) releasing quarterly updates on Wednesday. Did you see these…

    Read more »

    Share Market News

    Why I'd buy and hold a2 Milk shares until 2025

    Despite their recent growth, here's why I believe a2 Milk Company Ltd (ASX: A2M) shares are a great buy and…

    Read more »

    line graph superimposed over milking cows, a2 milk share price
    Share Market News

    Is the a2 Milk share price too high to buy?

    The A2 Milk share price has been one of the standout performers during the coronavirus crisis. Is it too late…

    Read more »

    a woman
    Share Market News

    Fund managers have been buying these ASX shares this week

    Fund managers have been buying ASX shares this week. Here's what they have been adding to their portfolios...

    Read more »

    a woman
    Share Market News

    This ASX infant formula share just reported explosive growth. Could it be the next a2 Milk?

    Could Nuchev Ltd (ASX: NUC) become the next A2 Milk Company Ltd (ASX: A2M)?

    Read more »

    a woman
    Share Market News

    2 ASX 200 companies playing a vital role in the coronavirus crisis

    Here, we look at 2 ASX companies playing a vital role in the coronavirus crisis – Metcash Limited (ASX: MTS)…

    Read more »

    a woman
    Share Market News

    3 ASX shares to buy with $3,000

    Whether you're buying shares for the first time or looking to add to your portfolio, here are 3 ASX share…

    Read more »

    a woman
    Share Market News

    3 top ASX growth shares to diversify your portfolio

    Here's why A2 Milk Company (ASX: A2M) and these other 2 top ASX growth shares are my picks for a…

    Read more »

    a woman
    Share Market News

    3 ASX growth shares to buy and hold beyond 2025

    Here's why I think these 3 ASX growth shares are great options to buy and hold until 2025 and beyond.

    Read more »

    NUC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Nuchev Ltd

    Nuchev Ltd is a globally-oriented food business focused on developing, marketing, and selling a range of premium Australian made goat nutritional products. Its primary products include its Oli6 branded goat infant formula and nutritional range, which are sold across multiple sales channels in Australia and China.

    NUC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    29 May 2024 $0.15 $-0.02 -12.12% 6,399 $0.15 $0.15 $0.15
    27 May 2024 $0.17 $0.02 13.42% 6,328 $0.16 $0.17 $0.16
    22 May 2024 $0.15 $-0.01 -6.29% 9,615 $0.15 $0.15 $0.15
    21 May 2024 $0.16 $0.01 6.94% 31,910 $0.16 $0.16 $0.16
    20 May 2024 $0.14 $0.00 0.00% 4,286 $0.15 $0.15 $0.14
    17 May 2024 $0.15 $0.00 0.00% 39,444 $0.14 $0.15 $0.14
    16 May 2024 $0.15 $-0.01 -6.29% 3,016 $0.15 $0.15 $0.15
    14 May 2024 $0.16 $0.00 0.00% 1,387 $0.16 $0.16 $0.16
    10 May 2024 $0.16 $0.00 0.00% 9,750 $0.16 $0.16 $0.16
    09 May 2024 $0.16 $0.00 0.00% 125,250 $0.15 $0.16 $0.15

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    16 Oct 2023 Ben Dingle Transfer 11,976,000 $2,095,800
    Off-market transfer.
    16 Oct 2023 Ben Dingle Transfer 11,976,000 $2,095,800
    Off-market transfer.
    29 Aug 2023 Ben Dingle Expiry 558,660 $106,145
    As advised by the company. Securities lapsed, As per announcement on 30-08-2023
    24 Aug 2023 Michelle Terry Transfer 44,572 $8,245
    Off-market transfer.
    24 Aug 2023 Michelle Terry Transfer 44,572 $8,245
    Off-market transfer.
    28 Jun 2023 Ben Dingle Issued 8,937,172 $1,787,434
    Rights issue.
    28 Jun 2023 Selina Lightfoot Issued 22,500 $4,500
    Rights issue.
    28 Jun 2023 Justin Breheny Issued 103,255 $20,651
    Rights issue.
    28 Jun 2023 Justin Breheny Issued 157,751 $31,550
    Rights issue.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Ben McFarlane Dingle Executive DirectorExecutive Chairman Apr 2013
    Ben is recognised as a highly connected, large scale dairy innovator and leader. He has extensive commercial experience in the wider dairy nutritional sector. Ben was also instrumental in the creation and management of a portfolio encompassing expansive dairy operations on the Canterbury Plains, which included approximately 15,000 cows. In this role, he established and implemented innovative irrigation schemes, and the incorporation of world best farming practices. Ben was a member and Chair of the Group's Strategy and M&A Committee.
    Ms Michelle Ruth Terry Non-Executive Director Nov 2019
    An experienced executive leader of ASX 50 companies, Michelle has over 20 years of experience in international markets across multiple sectors, including consumer goods, luxury goods, professional services, financial services and retail. She has worked across consumer goods in Asia, Australia, Europe, the Middle East, Africa, the United States and Latin America. Michelle is Chair of the Group's People
    & Culture Committee.
    Mr Jeffrey(Jeff) William Martin Non-Executive Director Nov 2019
    Jeff is the principal of Martin & Co Legal, a boutique Melbourne based legal practice that specialises in
    commercial, corporate, dispute resolution and commercial litigation, employment, family and estate law. Prior to his legal career, Jeff spent 25 years in food and dairy senior management positions, including 15 years within Nestle, five years as General Manager of SPC and five years as Managing Director of Tatura Milk Industries. Jeff is a member of the Group's Audit and Risk Committee and was also a member of the Group's Strategy and M&A Committee.
    Mr Craig Silbery Non-Executive Director Oct 2023
    Mr Silbery is a entrepreneur who established and led Life-Space Group from start-up to a exit with the sale to Guangzhou based By-Health in 2018. He built Life-Space around a core foundation of innovatve probiotic formulas for infants and pregnant women developed based on Human Microbiome science. He is also currently the founder and CEO of ilume, a wearable pet health venture
    Ms Tamara Barr Company Secretary Feb 2022
    -
    Mr Michael(Mick) Loe Myers Interim CEO Dec 2023
    -
    Tamara Barr Company Secretary
    -
    Michael(Mick) Loe Myers Interim CEO
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Ben Dingle 32,084,449 38.01%
    H&S Investments Australia Pty Ltd <H&S Investment Unit A/C> 16,797,049 19.90%
    HSBC Custody Nominees (Australia) Limited 12,793,825 15.16%
    Mr Craig Silbery 3,692,604 4.37%
    CW Investment Holdings A/C <CW Investment Holdings A/C> 1,030,000 1.22%
    Kirwood Capital Direct Investments 1 Pty Ltd <Kirwood Cap Direct Invest 1> 1,000,000 1.18%
    Superhero Securities Limited <Client A/C> 953,900 1.13%
    Justin Breheny 937,008 1.11%
    Gigo Investment Pty Ltd <Gigo A/C> 874,949 1.04%
    Ataturk Investments Pty Ltd 565,067 0.67%
    Top End Enterprises Pty Ltd <Atkins Super Fund A/C> 405,771 0.48%
    Daho Pty Ltd <The DHB S/F A/C> 350,000 0.41%
    Pacific Healthy International Holding Pty Ltd 317,097 0.38%
    Mr Pynith Charernsirivathin & Mrs Zina Christina Charernsirivathin 300,000 0.36%
    MF & SA Super Pty Ltd <MF & SA Super A/C> 277,000 0.33%
    Sharma Investments Pty Ltd <Sharma Invest Disc A/C> 245,771 0.29%
    Mango & Chubb Pty Ltd <Superannuation Fund A/C> 240,000 0.28%
    Mr Lawrence Wing Ming Ho & Mrs Ying Ho <L&Y Family Super Fund A/C> 235,919 0.28%
    MGD Strategic Acquisitions P/L <MGD Strat Acquisitions A/C> 228,545 0.27%
    Thomas Edward Dingle & Patricia Jessie Dingle <Clyde Hill A/C> 225,000 0.27%

    Profile

    since

    Note